Free

Business of Biotech Series

Event Information

Share this event

Date and Time

Location

Location

Alexion Pharmaceuticals

100 College Street

New Haven, CT 06510

View Map

Friends Who Are Going
Event description

Description

Business of Biotech is a lecture and workshop series dedicated to bridging the gap between academic researchers and the CT bioscience community.

Upcoming Events:

3-Day Kickoff:

Mon., Sept. 18: Elements of a Business Plan and Sources of Capital for Early Stage Life Science Companies with Colleen Cuffaro, Principal, Canaan Partners; Preston Noon, Agent Capital; Carrie Collins White, Investment Associate, Connecticut Innovations & Lou DeGennaro, President & CEO of Leukemia & Lymphoma Society.

Tues., Sept. 19: Keys to R to D to Market Translation with Erika Smith, CEO, ReNetX; Rachael Alford, VP, Global Product Development, Alexion Pharmaceuticals; Chris McLeod, Managing Partner at Elm Street Ventures; Demetrios Braddock, M.D., Ph.D.

Wed., Sept. 20: Intellectual Property and Regulatory Considerations for Early Stage Life Science Companies with David Harburger, Associate Patent Attorney, WSGR; Andrey Antov, Program Director of the Maine Cancer Genomics Initiative at The Jackson Laboratory and Andrew Hutchinson, Alexion Pharmaceuticals.

WSGR is looking for patent agents and scientific advisors for the patent group across national offices. If any interested students and postdocs attend, they are welcome to resume drop or email resumes after the event. Contact: dharburger@wsgr.com

**Have pizza at BAR with the speakers right after this session ends @ 7:30pm!

-----------------

Wed., Oct. 25: Course Introduction and Overview of Campus Resources & Introduction to the Biotech Landscape - companies, key players, sectors with Jim Boyle of the Office of Cooeprative Research and Susan Froshauer, President and CEO of Connecticut United for Research Excellence.

Mon., Nov. 20: Case Studies in Life Science Entrepreneurship (Early-stage Entrepreneurs) & Medical Devices/Therapeutics/Small Molecules.

Wed., Dec. 6: FDA Medical/Biotech: Clinical Phases/Checkpoints with Tim Shannon, General Partner of Canaan Partners and Marcia Dougan Moore, VP of Development Operations at Arvinas.

More dates to come!

Business of Biotech is supported by the Yale Office of Cooperative Research, WSGR and Alexion Pharmaceuticals.




Share with friends

Date and Time

Location

Alexion Pharmaceuticals

100 College Street

New Haven, CT 06510

View Map

Save This Event

Event Saved